178 related articles for article (PubMed ID: 11827749)
1. Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation.
Pizzimenti S; Laurora S; Briatore F; Ferretti C; Dianzani MU; Barrera G
Free Radic Biol Med; 2002 Feb; 32(3):233-45. PubMed ID: 11827749
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
Laurora S; Pizzimenti S; Briatore F; Fraioli A; Maggio M; Reffo P; Ferretti C; Dianzani MU; Barrera G
J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
[TBL] [Abstract][Full Text] [Related]
3. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
[TBL] [Abstract][Full Text] [Related]
4. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
Aoun P; Simpkins JW; Agarwal N
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
[TBL] [Abstract][Full Text] [Related]
5. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells.
Masamune A; Kikuta K; Satoh M; Sakai Y; Satoh A; Shimosegawa T
J Biol Chem; 2002 Jan; 277(1):141-7. PubMed ID: 11606585
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
Tsubouchi Y; Sano H; Kawahito Y; Mukai S; Yamada R; Kohno M; Inoue K; Hla T; Kondo M
Biochem Biophys Res Commun; 2000 Apr; 270(2):400-5. PubMed ID: 10753637
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
8. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
Takashima T; Fujiwara Y; Higuchi K; Arakawa T; Yano Y; Hasuma T; Otani S
Int J Oncol; 2001 Sep; 19(3):465-71. PubMed ID: 11494023
[TBL] [Abstract][Full Text] [Related]
9. PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
Simonin MA; Bordji K; Boyault S; Bianchi A; Gouze E; Bécuwe P; Dauça M; Netter P; Terlain B
Am J Physiol Cell Physiol; 2002 Jan; 282(1):C125-33. PubMed ID: 11742805
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
11. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
[TBL] [Abstract][Full Text] [Related]
12. 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.
Cerbone A; Toaldo C; Laurora S; Briatore F; Pizzimenti S; Dianzani MU; Ferretti C; Barrera G
Free Radic Biol Med; 2007 Jun; 42(11):1661-70. PubMed ID: 17462534
[TBL] [Abstract][Full Text] [Related]
13. The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis.
Harris SG; Phipps RP
Eur J Immunol; 2001 Apr; 31(4):1098-105. PubMed ID: 11298334
[TBL] [Abstract][Full Text] [Related]
14. PPAR alpha stimulates the rat gastrin-producing cell.
Bakke I; Hammer TA; Sandvik AK; Waldum HL
Mol Cell Endocrinol; 2002 Sep; 195(1-2):89-97. PubMed ID: 12354675
[TBL] [Abstract][Full Text] [Related]
15. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells.
Marra F; Efsen E; Romanelli RG; Caligiuri A; Pastacaldi S; Batignani G; Bonacchi A; Caporale R; Laffi G; Pinzani M; Gentilini P
Gastroenterology; 2000 Aug; 119(2):466-78. PubMed ID: 10930382
[TBL] [Abstract][Full Text] [Related]
16. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
[TBL] [Abstract][Full Text] [Related]
17. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
Inoue K; Kawahito Y; Tsubouchi Y; Kohno M; Yoshimura R; Yoshikawa T; Sano H
Biochem Biophys Res Commun; 2001 Sep; 287(3):727-32. PubMed ID: 11563856
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone.
Kawa S; Nikaido T; Unno H; Usuda N; Nakayama K; Kiyosawa K
Pancreas; 2002 Jan; 24(1):1-7. PubMed ID: 11741176
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M
J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343
[TBL] [Abstract][Full Text] [Related]
20. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma.
Takata Y; Kitami Y; Yang ZH; Nakamura M; Okura T; Hiwada K
Circ Res; 2002 Sep; 91(5):427-33. PubMed ID: 12215492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
